Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis

Lovastatin is a statin produced by Monascus purpureous-fermented pu-erh tea, which is used in the treatment of cardiovascular diseases and prostate cancer. Bacteria-mediated cancer immunotherapy (BCI), which is an effective antitumor strategy compared with conventional immunotherapies, targets neutr...

Full description

Bibliographic Details
Main Authors: Hong Zhang, Shaoting Sang, Huimin Xu, Linghua Piao, Xiande Liu
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Journal of Functional Foods
Subjects:
ERK
AKT
Online Access:http://www.sciencedirect.com/science/article/pii/S175646462100342X
id doaj-139b496c34b64a9a8696f34b5c84a86a
record_format Article
spelling doaj-139b496c34b64a9a8696f34b5c84a86a2021-09-05T04:40:05ZengElsevierJournal of Functional Foods1756-46462021-11-0186104693Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosisHong Zhang0Shaoting Sang1Huimin Xu2Linghua Piao3Xiande Liu4College of Animal Science and Technology, Hainan University, Haikou, ChinaSchool of Life and Pharmaceutical Sciences, Hainan University, Haikou, ChinaSchool of Life and Pharmaceutical Sciences, Hainan University, Haikou, ChinaDepartment of Physiology, Hainan Medical University, Haikou, China; Corresponding authors at: School of Life and Pharmaceutical Sciences, Hainan University, No. 58 Renmin Avenue, Haikou 570228, China (X. Liu). Department of Physiology, Hainan Medical University, No. 3 Xueyuan Avenue, Haikou 571199, China (L. Piao).School of Life and Pharmaceutical Sciences, Hainan University, Haikou, China; Corresponding authors at: School of Life and Pharmaceutical Sciences, Hainan University, No. 58 Renmin Avenue, Haikou 570228, China (X. Liu). Department of Physiology, Hainan Medical University, No. 3 Xueyuan Avenue, Haikou 571199, China (L. Piao).Lovastatin is a statin produced by Monascus purpureous-fermented pu-erh tea, which is used in the treatment of cardiovascular diseases and prostate cancer. Bacteria-mediated cancer immunotherapy (BCI), which is an effective antitumor strategy compared with conventional immunotherapies, targets neutrophil infiltration associated with tumor recurrence and metastasis. In mouse colon cancer models, combination treatment with lovastatin and BCI suppressed tumor progression by extending the survival of tumor-colonizing bacteria. We used zebrafish live imaging to show that lovastatin decreases the recruitment of neutrophils to the inflammatory site by inducing neutrophil apoptosis via phosphorylation of ERK and AKT. The present findings suggest that the combination of BCI with lovastatin or fermented pu-erh tea is an effective approach compared with conventional cancer immunotherapy.http://www.sciencedirect.com/science/article/pii/S175646462100342XBacteria-mediated cancer immunotherapyLovastatinNeutrophilsERKAKT
collection DOAJ
language English
format Article
sources DOAJ
author Hong Zhang
Shaoting Sang
Huimin Xu
Linghua Piao
Xiande Liu
spellingShingle Hong Zhang
Shaoting Sang
Huimin Xu
Linghua Piao
Xiande Liu
Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
Journal of Functional Foods
Bacteria-mediated cancer immunotherapy
Lovastatin
Neutrophils
ERK
AKT
author_facet Hong Zhang
Shaoting Sang
Huimin Xu
Linghua Piao
Xiande Liu
author_sort Hong Zhang
title Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
title_short Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
title_full Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
title_fullStr Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
title_full_unstemmed Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
title_sort lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis
publisher Elsevier
series Journal of Functional Foods
issn 1756-4646
publishDate 2021-11-01
description Lovastatin is a statin produced by Monascus purpureous-fermented pu-erh tea, which is used in the treatment of cardiovascular diseases and prostate cancer. Bacteria-mediated cancer immunotherapy (BCI), which is an effective antitumor strategy compared with conventional immunotherapies, targets neutrophil infiltration associated with tumor recurrence and metastasis. In mouse colon cancer models, combination treatment with lovastatin and BCI suppressed tumor progression by extending the survival of tumor-colonizing bacteria. We used zebrafish live imaging to show that lovastatin decreases the recruitment of neutrophils to the inflammatory site by inducing neutrophil apoptosis via phosphorylation of ERK and AKT. The present findings suggest that the combination of BCI with lovastatin or fermented pu-erh tea is an effective approach compared with conventional cancer immunotherapy.
topic Bacteria-mediated cancer immunotherapy
Lovastatin
Neutrophils
ERK
AKT
url http://www.sciencedirect.com/science/article/pii/S175646462100342X
work_keys_str_mv AT hongzhang lovastatinsuppressesbacterialtherapyinducedneutrophilrecruitmenttothetumorbypromotingneutrophilapoptosis
AT shaotingsang lovastatinsuppressesbacterialtherapyinducedneutrophilrecruitmenttothetumorbypromotingneutrophilapoptosis
AT huiminxu lovastatinsuppressesbacterialtherapyinducedneutrophilrecruitmenttothetumorbypromotingneutrophilapoptosis
AT linghuapiao lovastatinsuppressesbacterialtherapyinducedneutrophilrecruitmenttothetumorbypromotingneutrophilapoptosis
AT xiandeliu lovastatinsuppressesbacterialtherapyinducedneutrophilrecruitmenttothetumorbypromotingneutrophilapoptosis
_version_ 1717814587409039360